Published in Proc Natl Acad Sci U S A on August 01, 1967
Acquired pure red cell aplasia: updated review of treatment. Br J Haematol (2008) 1.88
Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest (1973) 1.08
The bone marrow in aplastic anaemia: diagnostic and prognostic features. J Clin Pathol (1974) 0.92
Erythroid colony growth in congenital hypoplastic anemia. J Clin Invest (1976) 0.92
Serum level of erythropoietin in anemias associated with chronic infection, malignancy, and primary hematopoietic disease. J Clin Invest (1971) 0.91
Stimulators and inhibitors of hepatic porphyrin formation in human sera. J Clin Invest (1974) 0.87
Neutropenia in three patients with rheumatic disorders. Suppression of granulopoiesis by control-sensitive thymus-dependent lymphocytes. J Clin Invest (1979) 0.86
Current methods for detecting antibodies against erythropoietin and other recombinant proteins. Clin Diagn Lab Immunol (2005) 0.84
The consequences of not having eosinophils. Allergy (2013) 0.83
Surgical pathology of the thymus: 20 years' experience. Thorax (1986) 0.81
Panhypoplasia of the bone marrow. I. Demonstration of a plasma factor with anti-erythropoietin-like activity. Can Med Assoc J (1968) 0.75
The proliferative capacity of pure red cell aplasia bone marrow cells. Yale J Biol Med (1981) 0.75
Fluorescent antibody staining. 3. Preparation of fluorescein-isothiocyanate-labeled antibodies. J Immunol (1965) 5.82
Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59
THE EFFECT OF ERYTHROPOIETIN UPON HEME SYNTHESIS BY MARROW CELLS IN VITRO. J Biol Chem (1963) 1.75
Benign thymoma and selective erythroid aplasia of the bone marrow. Cancer (1959) 1.52
Antinuclear factor and other antibodies in blood and liver diseases. Br Med J (1963) 1.45
Studies on erythropoiesis. V. The effect of cobalt on the production of erythropoietin. Blood (1958) 1.39
Inhibition of erythropoiesis by a factor present in the plasma of patients with erythroblastopenia. Blood (1966) 1.24
Studies on erythropoiesis. XVI. Response to a single dose of erythropoietin in polycythemic mouse. J Lab Clin Med (1961) 1.23
Mechanism of testosterone action in erythropoiesis. Nature (1965) 1.16
Splenectomy for pure red-cell hypoplastic (aregenerative) anemia associated with autoimmune hemolytic disease; report of a case. N Engl J Med (1954) 1.10
Erythropoietic effect of plasma from mice receiving testosterone. Nature (1965) 1.04
Cell antigens and cell specialization. I. A study of blood group antigens on normoblasts. Blood (1963) 0.93
RED-CELL APLASIA WITH CARCINOMA OF THE BRONCHUS. Br Med J (1964) 0.92
Studies on the effect of anti-bone-marrow-serum. Acta Med Scand (1951) 0.89
An adaptation of the Maximow technique for preparation of sections of hematopoietic tissues. J Lab Clin Med (1953) 0.87
The effect of erythropoietin on human bone marrow cells in vitro. Life Sci (1965) 0.86
Immunologic studies on the mechanism of action of erythropoietin. Proc Soc Exp Biol Med (1962) 0.85
Experimental production of bone marrow aplasia by immunological means. Acta Haematol (1962) 0.81
Experimental production of blood disorders in rat by injection of antierythroblastic, antileukoblastic and antimegakaryocytic sera. Acta Haematol (1951) 0.81
Progress in understanding the pathogenesis of the anemia of chronic disease. Blood (1992) 3.57
Inhibition of human erythroid colony-forming units by gamma interferon can be corrected by recombinant human erythropoietin. Blood (1991) 2.13
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol (1992) 1.97
Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood (1992) 1.96
Antigenic variation of Plasmodium knowlesi malaria: identification of the variant antigen on infected erythrocytes. Proc Natl Acad Sci U S A (1983) 1.83
Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med (1990) 1.79
Diagnosis and treatment of pure red cell aplasia. Med Clin North Am (1976) 1.73
Binding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cells. J Biol Chem (1987) 1.64
Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med (1984) 1.59
Evidence for mitotic recombination in the cellular slime mold Dictyostelium discoideum. Proc Natl Acad Sci U S A (1974) 1.56
A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem (2000) 1.54
Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood (1991) 1.50
Pure red-cell aplasia. N Engl J Med (1974) 1.49
Radioiodination of new protein antigens on the surface of Plasmodium knowlesi schizont-infected erythrocytes. Mol Biochem Parasitol (1982) 1.45
Erythroid bursts produced by Friend leukaemia virus in vitro. Nature (1978) 1.44
Erythropoietin and the control of red cell production. Annu Rev Med (1978) 1.43
Interferon gamma induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood (1999) 1.42
Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical response. Br J Haematol (1991) 1.40
Changes in cytoskeletal proteins and their mRNAs during maturation of human erythroid progenitor cells. J Cell Physiol (1994) 1.38
Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood (1995) 1.34
Studies on red cell aplasia. II. Report of a second patient with an antibody to erythroblast nuclei and a remission after immunosuppressive therapy. Blood (1969) 1.34
Cimetidine-induced neutropenia: a possible dose-related phenomenon. Arch Intern Med (1979) 1.32
Specific binding of erythropoietin to spleen cells infected with the anemia strain of Friend virus. Proc Natl Acad Sci U S A (1984) 1.32
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol (1998) 1.28
Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol (1987) 1.23
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J Clin Invest (1994) 1.21
Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest (1987) 1.21
Synergistic activation of MAP kinase (ERK1/2) by erythropoietin and stem cell factor is essential for expanded erythropoiesis. Blood (1998) 1.18
Red cell aplasia and chronic granulocytic leukaemia. Br J Haematol (1981) 1.15
Human colony-forming units-erythroid do not require accessory cells, but do require direct interaction with insulin-like growth factor I and/or insulin for erythroid development. J Clin Invest (1989) 1.15
Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood (1984) 1.14
Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol (1993) 1.13
Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol (1990) 1.13
Receptors for erythropoietin in mouse and human erythroid cells and placenta. Blood (1989) 1.13
Anemia of the critically ill: "acute" anemia of chronic disease. Crit Care Med (2000) 1.11
Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood (1988) 1.09
Studies on red cell aplasia. V. Presence of erythroblast cytotoxicity in G-globulin fraction of plasma. J Clin Invest (1973) 1.08
Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J Clin Invest (1994) 1.08
Target cells for Friend virus-induced erythroid bursts in vitro. Cell (1979) 1.08
The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum (1990) 1.07
On the mechanism of erythropoietin-induced differentiation. II. T he effect on RNA synthesis. Biochim Biophys Acta (1965) 1.06
Identification of the receptor for erythropoietin by cross-linking to Friend virus-infected erythroid cells. Proc Natl Acad Sci U S A (1987) 1.06
Transferrin receptor number, synthesis, and endocytosis during erythropoietin-induced maturation of Friend virus-infected erythroid cells. J Biol Chem (1986) 1.04
Upper airway obstruction as a complication of oral anticoagulation therapy. Report of three cases. Arch Intern Med (1979) 1.04
Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol (1992) 1.03
Increased sensitivity to complement or erythroid and myeloid progenitors in paroxysmal nocturnal hemoglobinuria. N Engl J Med (1983) 1.02
Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest (1993) 1.02
Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial. Am J Med Sci (1988) 1.01
Fas ligand is present in human erythroid colony-forming cells and interacts with Fas induced by interferon gamma to produce erythroid cell apoptosis. Blood (1998) 1.01
Response of polycythemia vera marrow to erythropoietin in vitro. J Lab Clin Med (1968) 1.00
Application of the in vitro erythropoietin system to the study of human bone marrow disease: polycythemia vera. Ann N Y Acad Sci (1968) 1.00
Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells. Clin Cancer Res (1998) 0.99
Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms. Blood (1984) 0.99
Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells. J Cell Physiol (1988) 0.97
Specific differentiation events induced by erythropoietin in cells infected in vitro with the anemia strain of Friend virus. Proc Natl Acad Sci U S A (1982) 0.97
Inhibition of human colony-forming-unit erythroid by tumor necrosis factor requires accessory cells. J Clin Invest (1990) 0.97
Mature erythroid burst-forming units are target cells for Friend virus-induced erythroid bursts. Virology (1981) 0.97
Effect of pure erythropoietin on DNA-synthesis by human marrow day 15 erythroid burst forming units in short-term liquid culture. Br J Haematol (1984) 0.96
Human burst-forming units-erythroid need direct interaction with stem cell factor for further development. Blood (1991) 0.95
Isolation of erythropoietin-sensitive cells from Friend virus-infected marrow cultures: characteristics of the erythropoietin response. Blood (1983) 0.94
Protein antigens of Plasmodium knowlesi clones of different variant antigen phenotype. Parasitology (1984) 0.93
Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells. Blood (1997) 0.93
Inhibition of heme synthesis induces apoptosis in human erythroid progenitor cells. J Cell Physiol (1995) 0.92
Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus. Proc Natl Acad Sci U S A (1980) 0.91
Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin. Blood (1972) 0.91
In vitro behavior of stem cells. J Lab Clin Med (1968) 0.90
Stem cell factor and erythropoietin inhibit apoptosis of human erythroid progenitor cells through different signalling pathways. Br J Haematol (2000) 0.90
In vitro expression of erythroid differentiation induced by Friend polycythaemia virus. Nature (1975) 0.89
Erythropoietin receptors in polycythemia vera. J Clin Invest (1989) 0.89
N-terminal amino acid sequence of the histidine-rich protein from Plasmodium lophurae. Mol Biochem Parasitol (1984) 0.89
Malignant histiocytoses developing in patients with B-cell lymphomas. Report of two cases. Cancer (1986) 0.88
Polycythaemia vera. IV. Specific binding of stem cell factor to normal and polycythaemia vera highly purified erythroid progenitor cells. Br J Haematol (1994) 0.87
Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum (1989) 0.87
Response of erythroid day 3 burst-forming units to endotoxin and erythropoietin. Proc Soc Exp Biol Med (1979) 0.87
The effect of erythropoietin on human bone marrow cells in vitro. Life Sci (1965) 0.86
Successful immunosuppressive treatment of erythroid aplasia appearing after thymectomy. Br J Haematol (1970) 0.86
The effect of Friend polycythemia virus on splenic uptake of 59 Fe in fasted mice. Proc Soc Exp Biol Med (1973) 0.86
Erythroid-specific processing of human beta spectrin I pre-mRNA. Blood (1994) 0.86
Erythropoietin stimulates 45Ca2+ uptake in Friend virus-infected erythroid cells. J Biol Chem (1984) 0.85
Inhibition of murine erythroid colony formation in vitro by interferon gamma and correction by interferon receptor immunoadhesin. Blood (1994) 0.85
Lack of effect of erythropoietin on cyclic adenosine-3',5'-monophosphate levels in rat fetal liver cells. J Lab Clin Med (1974) 0.84
Erythropoietin response to anemia as a function of age. J Am Geriatr Soc (1991) 0.84
Mode of action of the IgG inhibitor of erythropoiesis in transient erythroblastopenia of children. Blood (1982) 0.83
The effects of bevacizumab on postoperative complications in patients undergoing colorectal and pancreatic cancer resection. J Surg Oncol (2010) 0.82
On the mechanism of erythropoietin-induced differentiation. IV. Some characteristics of erythropoietin action on hemoglobin synthesis in marrow cell culture. Biochim Biophys Acta (1965) 0.82
Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3. J Clin Invest (1991) 0.82
Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement. J Lab Clin Med (1973) 0.82
Combined effect of friend polycythemia virus and erythropoietin on erythroid burst formation in vitro. Exp Hematol (1980) 0.82
Erythropoietin: biology and clinical use. Hematol Oncol Clin North Am (1989) 0.81
In vitro transformation of mouse hematopoietic cells by the spleen focus-forming virus. Cold Spring Harb Symp Quant Biol (1980) 0.81
Studies on pure red cell aplasia. X. Association with acute leukemia and significance of bone marrow karyotype abnormalities. Blood (1980) 0.81
Inhibition of human erythroid colony-forming units by interferons alpha and beta: differing mechanisms despite shared receptor. Exp Hematol (1996) 0.81
Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells. Blood (1991) 0.81
Cytotoxicity for erythroblasts in horse antihuman thymocyte -globulin. Transplantation (1973) 0.81
Quantitation of insulin-like growth factor-I binding to highly purified human erythroid colony-forming units. Exp Hematol (1991) 0.80
Retracted Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin. Blood (1999) 0.80
Editorial: Recent contributions to the mechanism of action and clinical relevance of erythropoietin. J Lab Clin Med (1973) 0.80